Literature DB >> 9605945

Hepatocyte growth factor accelerates restitution of intestinal epithelial cells.

S Nishimura1, M Takahashi, S Ota, M Hirano, H Hiraishi.   

Abstract

Many cytokines are involved in the repair of damaged tissue, and one of these, hepatocyte growth factor (HGF), is involved not only with liver regeneration but also in the repair of other tissues. To investigate the importance of HGF in the repair of the small intestine, we evaluated its effect and that of other growth factors in IEC-6 cells, an intestinal epithelial cell line derived from normal rat small intestine. Round "wounds" were made in confluent monolayers of IEC-6 by silicon rubber-tipped steel rods and various cytokines; transforming growth factor alpha (TGF-alpha), transforming growth factor beta1 (TGF-beta1), keratinocyte growth factor (KGF), and HGF, were added. We photographed the repaired monolayers every 24 h and calculated the ratios of areas not covered by cells to initial areas. Cell proliferation with TGF-alpha, TGF-beta, KGF, or HGF was examined in terms of [3H]-thymidine uptake. Finally, we determined c-met (the HGF receptor) mRNA in the IEC-6 cells by Northern blot hybridization. HGF was the most potent of the cytokines in accelerating repair of the damaged monolayer of IEC-6. HGF was also 1.34 times more effective than control the medium for inducing cell proliferation of IEC-6. By Northern blot hybridization, three bands of mRNA bound to c-met cDNA. These results suggest that HGF is important in the repair of the small intestine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605945     DOI: 10.1007/s005350050066

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

Review 1.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 2.  Cellular and molecular mechanisms of the epithelial repair in IBD.

Authors:  Ryuichi Okamoto; Mamoru Watanabe
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 3.  Novel agents in the treatment of intestinal failure: humoral factors.

Authors:  Hua Yang; Daniel H Teitelbaum
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 4.  Epithelial-mesenchymal interactions in pulmonary fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Semin Respir Crit Care Med       Date:  2006-12       Impact factor: 3.119

5.  Effects of hepatocyte growth factor on rat inflammatory bowel disease models.

Authors:  Yoshio Ohda; Kazutoshi Hori; Toshihiko Tomita; Nobuyuki Hida; Tadashi Kosaka; Yoshihiro Fukuda; Hiroto Miwa; Takayuki Matsumoto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 6.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 7.  Progress in researches about focal adhesion kinase in gastrointestinal tract.

Authors:  Hui-Fang Hao; Yoshio Naomoto; Xiao-Hong Bao; Nobuyuki Watanabe; Kazufumi Sakurama; Kazuhiro Noma; Yasuko Tomono; Takuya Fukazawa; Yasuhiro Shirakawa; Tomoki Yamatsuji; Junji Matsuoka; Munenori Takaoka
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

Review 8.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

9.  Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation.

Authors:  Yalin Liao; Bo Lönnerdal
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

Review 10.  Novel therapies for the management of short bowel syndrome in children.

Authors:  Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.